May 05, 2026
https://www.finanznachrichten.de/nachrichten-2026-05/68410294-cellcentric-announces-oversubscribed-dollar-220-million-series-d-financing-to-advance-pivotal-trials-of-inobrodib-in-multiple-myeloma-004.htm
Pfizer, Inc. has invested $220M in CellCentric Limited